Healthy Skepticism Library item: 6829

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Claribid (clarithromycin)
1998 Oct;

Abstract:

The promotional literature for Claribid (clarithromycin) in India from Abbott could be interpreted to mean that this drug is a first-line therapy in a number of conditions. The scientific literature does not support this conclusion.

Keywords:
*analysis/India/developing countries/antibiotics/Claribid/clarithromycin/Abbott/quality of information/Medical Lobby for Appropriate Marketing/MaLAM/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS